In 1992, the ethnobotanist and lecturer Terence McKenna published Food of the Gods: The Search for the Original Tree of Knowledge, a book that argued something most of his contemporaries were not prepared to say out loud. The book's thesis was that human beings are, in a biological and cultural sense, the species that ate the mushroom — that psychoactive plants had been the catalyst for symbolic cognition, religious imagination, and the very invention of meaning. But nested inside that larger argument was a smaller, more political claim. Somewhere between the late Roman Empire and the reign of Harry Anslinger, McKenna wrote, Western civilization had conducted a thousand-year war against the plants that had made it possible. It had called the war many things — heresy, witchcraft, addiction, degeneracy, public health — but it was, at every stage, the same war. Those who held political power understood that a population which could alter its own Consciousness at will was a population that could not be fully controlled. So the keys were taken away, and the rooms they opened were declared not to exist.
McKenna did not coin the phrase "pharmacratic inquisition." That term was introduced by the psychiatrist Thomas Szasz, whose 1974 book Ceremonial Chemistry named the phenomenon "pharmacracy" — rule by means of drug regulation. Szasz argued that the modern state's relationship to chemicals was functionally identical to the medieval church's relationship to rituals: a ruling authority designating certain compounds sacramental and certain compounds diabolical, enforcing the distinction with prisons instead of pyres, and claiming medical authority where the Inquisition had claimed divine. Filmmakers Jan Irvin and Andrew Rutajit later fused the two framings in their 2006 documentary The Pharmacratic Inquisition, and the phrase stuck. What they named was older than any of them. It was the shape of the thing itself.
This node is the long history of that shape — from the destruction of the Eleusinian Telesterion in 396 CE to the FDA's 2024 breakthrough designation hearings on MDMA-assisted therapy — across the half-dozen distinct institutional regimes (Roman Christianity, the medieval Inquisition, the Spanish colonial church, the Anglo-American colonial drug administration, the early-twentieth-century federal narcotics bureaucracy, and the contemporary Schedule I regulatory complex) through which the same fundamental operation has been continuously executed under successively secularized names. The institutions change. The names change. The function does not. A ruling order, whatever its theology, reserves to itself the right to determine what minds are permitted to do.
For nearly two thousand years, initiates walked the Sacred Way from Athens to the temple complex at Eleusis, where they drank the kykeon — a barley-based beverage that, as R. Gordon Wasson, Albert Hofmann, and Carl Ruck argued in The Road to Eleusis (1978), was almost certainly psychoactive through ergot contamination. The rites were the spiritual center of classical civilization. Plato was an initiate. Sophocles, Aristotle, Cicero, Marcus Aurelius. Pindar wrote that "blessed is he who has seen these things before he goes beneath the earth; for he understands the end of mortal life, and the beginning of a new life given of god." Cicero, in De Legibus, called the Mysteries "the most sacred of all that Athens has given to the world" and wrote that through them "we have learned the principles of life, and gained the power not only to live with joy, but also to die with better hope." The Altered States induced at Eleusis were not marginal to Greek culture. They were its hidden heart.
The Wasson-Hofmann-Ruck thesis is precise about the chemistry. The barley grown in the Rharian Field surrounding Eleusis would, in the wet Mediterranean climate, have been routinely infected with Claviceps purpurea — the ergot fungus from which Hofmann had isolated lysergic acid diethylamide in 1938. The ergot alkaloids include water-soluble compounds (ergonovine and lysergic acid amide) capable of producing intense visionary states without the toxic vasoconstriction that makes raw ergot otherwise lethal. The two-day ritual at Eleusis included a fast, a long procession, sensory deprivation in the pitch-dark Telesterion, and finally the drinking of the kykeon and the witnessing of the epopteia — the great vision. The participants emerged transformed. The secrecy obligation surrounding the rite's content was so absolute that, in the entire two thousand years of the Mysteries' operation, no full description of what was actually witnessed has ever survived in the historical record.
In 392 CE, the Christian emperor Theodosius I issued an edict (Codex Theodosianus 16.10.12) banning all pagan rites across the Roman Empire under penalty of death. The Eleusinian Mysteries, the Olympic Games, the Delphic oracle, the Vestal fires, the entire ritual infrastructure of Mediterranean civilization, were criminalized in a single decree. In 396, Alaric the Visigoth, accompanied by Arian Christian monks who had identified the Telesterion specifically as a target of religious importance, sacked Eleusis. The temple complex was destroyed. The hierophantic line — the priestly succession through which the rite had been transmitted across two millennia — was extinguished. The Mysteries were over. The line of transmission that had produced Plato's philosophy and Aeschylus's tragedies was severed not because the rites had failed but because a new political theology required them to stop.
This is the first recognizable act of the inquisition McKenna described: the deliberate erasure, by state-backed religious authority, of a legitimate practice for altering consciousness. Not because the practice was ineffective. Precisely because it was effective, and it was not under control. The new sacrament that Theodosius's edict designated as the only legal access to transcendent experience — the Eucharist of the institutional Christian church — was administered exclusively by the priesthood, in controlled conditions, with no psychoactive content. The model that would persist for the next sixteen hundred years was set in 392. The state monopoly on legitimate altered states had been declared.
The pattern repeated itself, with greater ferocity, during the European witch trials of the fifteenth through seventeenth centuries. Between forty thousand and sixty thousand people — the lower-bound estimate of Brian Levack and the upper-bound estimate of Wolfgang Behringer — were executed across Europe during the peak of the persecution from approximately 1450 to 1750. Approximately seventy-five to eighty percent of the executed were women. The overwhelming majority were peasants. Disproportionately, they were the keepers of village herbal knowledge: midwives, healers, women who knew which plants treated which ailments, which mushrooms were safe and which were not, which preparations could ease childbirth and which could end an unwanted pregnancy. The official reason for their execution was pact with the devil. The anthropologist Michael Harner, in his 1973 essay "The Role of Hallucinogenic Plants in European Witchcraft" (collected in Hallucinogens and Shamanism), proposed a considerably more material explanation.
The flying ointments described in Inquisitorial records — greases applied to the body, particularly to mucous membranes, reported to induce sensations of flight, animal transformation, and encounters with spirit-beings — contained alkaloids from the Solanaceae family: Atropa belladonna, Hyoscyamus niger (henbane), Mandragora officinarum (mandrake), Datura stramonium. These are powerful deliriants whose active compounds (atropine, scopolamine, and hyoscyamine) cross the dermal barrier when applied in animal-fat suspensions. The reported subjective effects in the trial transcripts — the sensation of nocturnal flight, transformation into animals, encounters with the Devil at the sabbath — match the documented psychopharmacology of these alkaloids with a precision that historical-fictional invention would not produce. The witches were not lying about their experiences. They were describing the genuine subjective effects of a real ethnobotanical practice that the Inquisition was prosecuting under the legal-theological framework available to it.
The ethnobotanical case, which Carlo Ginzburg extended in Ecstasies: Deciphering the Witches' Sabbath (1989), is that a real substratum of pagan-shamanic plant practice persisted in rural Europe long after the official Christianization of the continent, and that the witch hunts were, in significant part, the forcible suppression of that underground pharmacology. Ginzburg's I Benandanti (1966) had earlier documented the Friulian "good walkers" — Italian peasants prosecuted by the Inquisition in the sixteenth and seventeenth centuries for their visionary nighttime journeys to fight evil witches over the fertility of the harvest. The Inquisitors initially could not even classify these self-identified Christians as heretics; their visionary practice did not fit the existing categories. The trial records show the Inquisitors slowly retraining the benandanti themselves, across decades of interrogation, to describe their own experiences in the demonological vocabulary the Inquisition required. By the late seventeenth century, the surviving benandanti were confessing to participation in the demonic sabbath. The visionary practice itself was unchanged. The legal framework around it had been imposed from above.
A related thread connects the European persecution to the most famous American instance. In 1976, the historian Linnda Caporael published "Ergotism: The Satan Loosed in Salem?" in Science, arguing that the 1692 Salem witch trials had occurred against a background of mass ergot poisoning produced by unusually wet weather and rye-grain contamination in the Massachusetts Bay Colony. The convulsions, hallucinations, and burning sensations the afflicted girls reported — and that subsequent generations of historians have struggled to explain as mass hysteria — match the documented symptomatology of ergot poisoning with substantial specificity. Caporael's thesis has been contested (most prominently by Nicholas Spanos and Jack Gottlieb in 1976 and by Mary Matossian in 1989), and the question of whether ergot was the proximate cause of the Salem episode remains open. What is not contested is the broader observation: the same ergot fungus that the Eleusinian Mysteries appear to have ritually administered in controlled doses for two millennia produced, in uncontrolled and unrecognized form, the legal pretext for the most famous witch trial in American history. The compound was identical. The cultural framework around it determined whether the experience was sacred initiation or demonic possession.
The women burned at the stake during the European persecution were, many of them, the last inheritors of an unbroken tradition of European plant medicine. When they were killed, the tradition was killed with them. The Inquisition burned not only the women but the books — the manuscript herbals, the village healers' notebooks, the accumulated empirical knowledge of which plants did what. The Bull of Innocent VIII (1484), Summis desiderantes affectibus, formally authorized the persecution; the Malleus Maleficarum (1487), authored by the Dominican inquisitors Heinrich Kramer and Jacob Sprenger, provided the operational manual. The church confiscated the keys and declared the rooms haunted. The ethnobotanical knowledge that survived in Europe after 1700 survived in fragments, smuggled from peasant grandmothers to grandchildren, never written down, slowly attenuating across the next two centuries until its recovery began in the late nineteenth-century occult revival and was completed only in the 1960s ethnobotanical work of Wasson, Schultes, and Hofmann.
When Spanish missionaries arrived in Mesoamerica, they encountered cultures whose ceremonial life was built around psychoactive plants to a degree they had never imagined. The Aztecs used psilocybin mushrooms, which they called teonanácatl — "flesh of the gods." They used the morning-glory seeds ololiuqui, which contain LSD-related ergoline alkaloids (lysergic acid amide and lysergic acid hydroxyethylamide). They used peyote (Lophophora williamsii), a small spineless cactus containing mescaline. They used salvia divinorum, Bufo alvarius toad venom (containing 5-MeO-DMT), the seeds of Anadenanthera peregrina, the smoke of various tobaccos at concentrations that produced visionary states (Nicotiana rustica, far more potent than the cultivated N. tabacum). The sacramental pharmacopeia of the Americas was immense, ancient, and central to religious practice. The Spanish chronicler Bernardino de Sahagún, in his 1577 Historia general de las cosas de Nueva España (the Florentine Codex), documented the mushroom rites in ethnographic detail precisely in order to stamp them out. He wrote, of the teonanácatl ceremony: "They ate them with honey, and when they began to feel excited they began to dance, some sang, others cried, for they were already drunk from the mushrooms; some did not want to sing but sat down in their rooms and remained there as if pensive; and some saw in vision that they were dying and cried; others saw themselves being eaten by a wild beast." The colonial church was clear about what it was looking at. It was a rival sacrament, and it had to be eliminated.
The Spanish response was systematic. The First Mexican Provincial Council in 1555 formally condemned the use of peyote. The Inquisition's June 29, 1620 edict in New Spain — issued by Inquisitor General Pedro Nabarre de Isla — declared the consumption of peyote an act of heresy, explicitly placing it on the legal-theological footing of communion with the devil. The edict's wording is precise: "the use of the herb or root called Peyote ... is a superstitious action and reproved as opposed to the purity and sincerity of our Holy Catholic Faith ... the said Peyote and any other herb employed for similar purpose, whatever its name, [is hereby] prohibited." The edict authorized the Inquisition to prosecute peyote users with the full institutional apparatus that had been developed for the persecution of heretics in Europe. Trial records preserved in the Mexican National Archive document approximately ninety formal Inquisition cases against peyote users between 1620 and 1779, with sentences ranging from public penance to lashings to imprisonment.
The institutional framing of the 1620 edict deserves attention. The peyote prohibition did not, on its surface, claim to be about public health. It was about jurisdiction over the sacred. The plant granted access to gods the Catholic Church did not authorize. Therefore the plant was the devil's. This is the inquisition in its most naked form: a ruling theological authority confronting a rival access to transcendent experience and criminalizing it on explicitly competitive religious grounds. The same logical structure would, three hundred years later, be reproduced in the secular drug-control regime, with "addiction" and "public safety" replacing "heresy" and "devil-worship" but the underlying institutional operation unchanged.
For four hundred years after contact, the indigenous use of teonanácatl was conducted in secret. It was not rediscovered by outsiders until 1955, when R. Gordon Wasson, accompanied by the Mazatec curandera María Sabina, participated in a mushroom ceremony in Huautla de Jiménez and published a photo-essay about it in Life magazine in May 1957 — an event that seeded the Western psychedelic counterculture of the following decade, and that cost María Sabina her home and livelihood when her community turned on her for revealing the sacrament. She lived to see hippies arrive in Huautla in such numbers that the Mexican government eventually closed the town to outsiders, and she died in poverty in 1985. The four-hundred-year underground transmission survived the Spanish Inquisition. It did not survive Wasson's Life magazine article. The cultural protection that secrecy had provided dissolved within two generations of its exposure to mass media — a pattern that would recur, with variations, in every subsequent Western contact with indigenous psychedelic traditions.
The transition from the religious-theological inquisition to the modern bureaucratic-secular one runs through the colonial drug administration of the late nineteenth and early twentieth centuries. The British East India Company's opium monopoly in Bengal, which generated by the 1830s approximately fifteen percent of total British Indian government revenue, was the first modern state-managed drug enterprise. The Opium Wars (1839-1842 and 1856-1860) were conducted to compel the Chinese Empire to legalize the British opium trade after the Chinese government's attempts to suppress it. The 1842 Treaty of Nanking and the 1858 Treaty of Tientsin established the legal framework under which British, French, and eventually American merchants flooded the Chinese market with Indian opium — producing, by the 1890s, an estimated ten to twenty million Chinese opium addicts, the largest narcotic dependency crisis in human history to that point.
The political effect was the inverse of what subsequent American drug policy would replicate. The colonial drug regime was a profit center for the colonizing power and a public-health catastrophe for the colonized. When opposition to the British opium trade emerged within Britain itself in the late nineteenth century — driven by missionary organizations and by the broader humanitarian reformism of the period — the response was institutional rather than commercial. The 1909 Shanghai Opium Commission, the 1912 International Opium Convention at The Hague, and the postwar establishment of the Opium Section of the League of Nations Secretariat created the international legal architecture for modern drug control. The first international treaty obligation to suppress non-medical opiate use entered force in 1919 as part of the Treaty of Versailles. The architecture was designed by the same European powers that had spent the previous century compelling China to accept the trade they were now criminalizing.
This international architecture provided the legal backstop for what Harry Anslinger would build at the federal level in the United States across the 1930s through the 1960s. The treaty framework — the 1925 Geneva Opium Convention, the 1931 Convention for Limiting the Manufacture and Regulating the Distribution of Narcotic Drugs, the 1936 Convention for the Suppression of the Illicit Traffic in Dangerous Drugs — required signatory states to enact domestic legislation prohibiting the non-medical manufacture, distribution, and possession of the listed compounds. The United States ratified each. The Bureau of Narcotics that Anslinger would direct from 1930 to 1962 was, in part, the domestic enforcement arm of an international regime whose architecture had already been settled before his appointment. What Anslinger added was the racial-political content of the prohibition's domestic application.
The modern American drug regime was not the accidental accumulation of reasonable public-health decisions. It was, to a degree that is no longer seriously contested, the product of one man's career. Harry Jacob Anslinger became the first commissioner of the Federal Bureau of Narcotics in 1930, and he held the position for thirty-two years. Johann Hari's 2015 book Chasing the Scream documents in exhaustive archival detail what Anslinger actually did with that time. The principal academic source is David Musto's The American Disease: Origins of Narcotic Control (1973, expanded 1987). Together, these and the supporting archival work conducted at the Penn State Anslinger papers establish the historical record beyond reasonable dispute.
Anslinger inherited a tiny agency with an uncertain mandate. The 1914 Harrison Narcotics Tax Act had nominally federalized opiate and cocaine regulation, but enforcement was weak and the Bureau of Prohibition (within which the narcotics function had previously sat) was being dismantled with the impending repeal of alcohol prohibition. To make his agency indispensable, Anslinger needed enemies. He constructed them. Marijuana, a substance most Americans had never heard of in 1930 — and that the American Medical Association had only just stopped recommending as a treatment for various conditions — was transformed in his public testimony and press campaigns into a demonic scourge. The campaign deployed two parallel framings, calibrated for different audiences. To the broad public, marijuana caused psychosis, violence, and the sexual corruption of women. To the regional press of the South and Southwest, it was the drug that drove Black men to rape white women and Mexican men to commit unspeakable violence. His own files, preserved at Penn State University and catalogued by Hari, contain the racial coding in explicit terms. Anslinger personally maintained a surveillance file on Billie Holiday, targeted her for arrest beginning in 1939 over her performance of "Strange Fruit" — Lewis Allan's anti-lynching song that the FBN regarded as politically intolerable — and harassed her on her deathbed in 1959, sending agents to her hospital room to handcuff her to her bed and to confiscate her methadone, contributing directly to the conditions of her death.
The Marihuana Tax Act of 1937 — the foundational statute of American cannabis prohibition — was passed on the basis of congressional testimony that was, even by the standards of the era, transparent fabrication. The congressional hearings ran for two days in the House Ways and Means Committee in the spring of 1937. The principal expert witness for the bill was Dr. James C. Munch, a Temple University pharmacologist who testified, under oath, that marijuana use had caused him to believe he had been turned into a bat. (Munch later served, in the 1970s, as an FBN consulting expert on the basis of this testimony; his bat experience was not contested by the committee.) The American Medical Association formally opposed the bill. Dr. William C. Woodward, the AMA's general counsel, testified that the Bureau of Narcotics had not provided the AMA with the evidence on which the proposed regulation was based, that the medical literature did not support Anslinger's claims, and that the bill would interfere with legitimate medical use of cannabis preparations. The committee chairman dismissed Woodward's testimony with hostile cross-examination. The bill passed the House by voice vote — no recorded vote was taken — and was signed into law on August 2, 1937. Within weeks, the Bureau of Narcotics had its first cannabis arrest. Within two years, the AMA had withdrawn cannabis from the U.S. Pharmacopoeia under pressure from Anslinger's agency.
The Boggs Act of 1951 and the Narcotic Control Act of 1956 added the institutional architecture of mandatory minimum sentencing. The Boggs Act established a two-to-five-year mandatory minimum for first-offense possession of any prohibited narcotic, with no judicial discretion to suspend sentence or grant probation. The Narcotic Control Act increased the penalties to five years for first offenses and ten to forty years for second offenses, and authorized the death penalty for the sale of heroin to minors. Anslinger lobbied for both bills. The institutional logic was identical to the Marihuana Tax Act's: the agency's continued political relevance required the continued production of arrests, and arrests required the legal infrastructure that mandatory sentencing provided. Across the 1950s, federal narcotics arrests rose from approximately three thousand per year in 1950 to approximately eight thousand per year in 1960. The arrests were disproportionately concentrated in Black urban neighborhoods. The pattern that Nixon would scale and Reagan would industrialize was already in operation under Anslinger's administration.
The inquisition had not disappeared. It had been secularized, bureaucratized, and given a federal budget. The theological framing was replaced by a medicalized one, but the underlying operation was the same: a ruling authority designating certain substances sacramental (alcohol, tobacco, caffeine, eventually the pharmaceutical industry's own serotonergic compounds) and certain substances diabolical (cannabis, cocaine, opium, and eventually the psychedelics), and enforcing the distinction with state violence. The 1620 Inquisitorial edict against peyote and the 1937 Marihuana Tax Act differ in vocabulary, jurisdiction, and theological framework. They do not differ in operation. A ruling order is identifying a substance whose use it does not authorize and prohibiting that use under criminal penalty.
Between 1943 — when Albert Hofmann accidentally absorbed lysergic acid diethylamide through his fingertips at the Sandoz laboratory in Basel — and 1968 — when the Drug Abuse Control Amendments criminalized LSD possession at the federal level — the compound was the subject of one of the most active research programs in the history of psychiatry. Sandoz distributed LSD-25 free of charge to qualified researchers under the trade name Delysid, with the accompanying literature suggesting two principal research applications: as a tool for inducing model psychoses for the study of schizophrenia, and as an adjunct to psychotherapy for various conditions. By 1965, more than a thousand research papers had been published on LSD's clinical applications. Approximately forty thousand patients had received LSD in clinical settings worldwide. The compound was used with reported success in the treatment of alcoholism (by Humphry Osmond and Abram Hoffer in Saskatchewan, with claimed remission rates substantially exceeding any contemporary alternative), depression, end-of-life anxiety in cancer patients (at Spring Grove State Hospital under Stanislav Grof, Walter Pahnke, and Albert Kurland), and a range of psychiatric conditions for which conventional therapeutics were ineffective. The 1965 Senate hearings on what would become the Drug Abuse Control Amendments included testimony from senior psychiatric researchers warning Congress that criminalizing the compound would terminate a research program of substantial therapeutic promise. The amendments passed.
The window closed in stages across the 1965-1973 period. In April 1966, Sandoz, citing the political climate around the compound, voluntarily withdrew Delysid from the market and recalled its outstanding research distributions. The action was unprecedented for a pharmaceutical that had no documented record of clinical harm in research settings. Spring Grove's psilocybin program was forced to terminate. Timothy Leary, dismissed from Harvard in May 1963 over the Harvard Psilocybin Project's procedural irregularities, was prosecuted on cannabis charges across the late 1960s and sentenced in 1970 to thirty-eight years in prison. The Controlled Substances Act of 1970 — the central legislative architecture of the modern American drug regime — placed LSD, psilocybin, mescaline, DMT, and a range of related compounds in Schedule I, the most restrictive classification, reserved for substances with "no currently accepted medical use" and "high potential for abuse." Cannabis was placed in Schedule I as a temporary measure pending the report of the Shafer Commission. The 1971 Convention on Psychotropic Substances, drafted at the U.S. delegation's insistence, internationalized the Schedule I framework and required signatory states to enact domestic legislation prohibiting the non-medical use of the listed compounds. By 1973, the institutional infrastructure of modern psychedelic prohibition was complete.
The closing of the research window had a specific political function that is sometimes lost in narratives that treat it as a moral or public-health response to "abuse." The compounds had been associated, by the mid-1960s, with the broader counterculture that the Vietnam War had radicalized. The psychedelic experience — whatever its actual content — had shown a tendency to produce, in the Americans who had it, a measurable shift in political and cultural attitudes that the institutional establishment found intolerable. As Counterculture as Psyop documents, the institutional response to the counterculture was complex and multi-layered, including direct intelligence operations against its principal organizations. The criminalization of the compounds was the legal arm of that response. Once the molecules were illegal, the practices that had grown around them could be policed out of public life. The therapeutic literature was set aside not because it had been refuted but because the political calculation had shifted. The research programs that had operated for two decades under Sandoz distribution were terminated. The clinicians who had been using the compounds were forced to choose between abandoning their work and conducting it underground. Most chose the former.
The full architecture of the modern inquisition was assembled in 1970. That year, President Richard Nixon signed the Controlled Substances Act, which established the federal scheduling system that remains in force today. Schedule I — the most restrictive classification, reserved for substances with "no currently accepted medical use" and "high potential for abuse" — included LSD, psilocybin, mescaline, DMT, cannabis, and MDMA (added in 1985). It did not include cocaine, methamphetamine, fentanyl, or oxycodone. The scheduling was not built on evidence. It was built on a political map.
In 1994, the journalist Dan Baum interviewed John Ehrlichman, Nixon's former domestic policy chief, for his book Smoke and Mirrors. Ehrlichman, by then a Watergate convict and late-life truth-teller, said the following on the record — a quote Baum published in Harper's Magazine in April 2016:
"The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and black people. You understand what I'm saying? We knew we couldn't make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did."
Members of Ehrlichman's family have contested the quote's full accuracy. Baum stood by it. Whether or not it is verbatim, the policy record is unambiguous. Nixon convened the National Commission on Marihuana and Drug Abuse — the Shafer Commission — in 1971 to study marijuana, with Pennsylvania Governor Raymond P. Shafer, a Nixon political ally, as chairman. The Commission included nine of Nixon's appointees, two members appointed by the Speaker of the House, and two by the President pro tempore of the Senate. Its mandate was to provide the scientific basis on which marijuana would be permanently scheduled. The Commission conducted approximately fifty public hearings, commissioned more than fifty research studies, and produced a 1,184-page report.
The Commission's central conclusion, delivered to Nixon on March 22, 1972, was the opposite of what Nixon had expected. Marihuana: A Signal of Misunderstanding recommended the decriminalization of marijuana possession for personal use. The report concluded: "Considering the range of social concerns in contemporary America, marihuana does not, in our considered judgment, rank very high. We would deemphasize marihuana as a problem ... society should seek to discourage use, while concentrating its attention on the prevention and treatment of heavy and very heavy use." The Commission found that marijuana caused no significant physical or mental health damage in moderate use, that the existing criminal penalties were disproportionate, and that decriminalization would substantially reduce the social costs of enforcement without producing significant increases in use.
Nixon rejected the report on the spot, in front of his staff, in a White House meeting documented in the subsequently released Nixon tapes. He had not read it. He told his aides he did not need to read it. The recommendation contradicted his political position, and the political position would not change. The report was buried. Marijuana was scheduled in Schedule I in 1972 on a permanent basis. The Commission's underlying research, which had produced extensive new data on cannabis pharmacology and use patterns, was set aside and was not seriously revisited by the federal scheduling apparatus for the next forty years. The Schafer Commission is the canonical case in American drug policy of a federally commissioned scientific advisory body whose conclusions were rejected on the day of submission for explicitly political reasons. The institutional pattern would repeat: the Reagan administration's 1988 review of the cannabis schedule by DEA Administrative Law Judge Francis Young (who recommended rescheduling on the basis that "marijuana, in its natural form, is one of the safest therapeutically active substances known to man") was rejected by DEA Administrator John Lawn. The 1999 Institute of Medicine report on medical marijuana, commissioned by the Office of National Drug Control Policy under General Barry McCaffrey, found substantial therapeutic potential and recommended further research; the report was set aside. The pattern is structural. The scheduling is political. The science follows the politics rather than the other way around.
The ugliest feature of the American inquisition is that, while it was suppressing public access to psychedelics, the same state was funding the most aggressive psychedelic research program in history. MKUltra ran from 1953 to 1973 — almost perfectly overlapping the period in which LSD was moving from an obscure laboratory compound to a scheduled drug. Sidney Gottlieb, the program's chemist-in-chief, purchased through Eli Lilly the production capacity that made the United States, by the late 1950s, the largest producer of LSD outside the Sandoz laboratory itself. The compound was administered to approximately 7,500 American military personnel at Edgewood Arsenal across the late 1950s and 1960s under various Defense Department research authorities. It was administered to unwitting civilian subjects under MKUltra Subproject 3 (the San Francisco safe house operations directed by George Hunter White from 1953 through 1965), Subproject 8 (Harold Abramson's research at Mount Sinai Hospital in New York), and a substantial number of related sub-projects whose specifics Gottlieb destroyed in 1973 along with the bulk of the MKUltra documentary record. Stephen Kinzer's Poisoner in Chief: Sidney Gottlieb and the CIA Search for Mind Control (2019) is the definitive account.
This was not an accident. It was not a coordination failure between agencies. It was the logic of the inquisition in its purest form: a ruling apparatus reserving for itself a technology that it was actively denying to its subjects. The medieval church did the same thing when it declared the Eucharist sacred, prosecuted lay mystics who claimed direct access, and then consumed the sacrament itself every Sunday. What is suppressed for the public is cultivated for the priesthood. The pharmacratic form of this arrangement is merely its modern dress. Martin Lee and Bruce Shlain's Acid Dreams: The Complete Social History of LSD (1985) develops the convergence in extensive documentary detail. The agency that funded the research, supplied the compounds, and trained the chemists was, simultaneously, the agency whose institutional partners in the federal narcotics bureaucracy were prosecuting the research's civilian descendants under the legal architecture the same agency had helped construct.
The institutional overlap is structural. The DEA was created in July 1973 — the same year MKUltra was officially terminated and its files destroyed under Helms's order. The personnel, the legal infrastructure, and the political will flowed from the same sources. The The Deep State component of this is not conspiratorial; it is administrative. Scheduling decisions, international treaty obligations (the 1971 Convention on Psychotropic Substances), DEA enforcement priorities, NIDA research funding, and the institutional gatekeeping of pharmaceutical research access to scheduled compounds are set by a permanent bureaucracy that has survived every president since Nixon without substantial change. The inquisition does not depend on any single administration. It is the machine.
The selective enforcement dimension produces, downstream, the CIA Drug Trafficking pattern. The same federal narcotics apparatus that prosecuted American cannabis users at industrial scale across the 1970s and 1980s did not interfere with the Hmong opium that flowed through Air America during the secret war in Laos, the Contra cocaine that flowed through Mena across the 1980s, or the Afghan heroin that flowed through Pakistani ISI distribution networks during Operation Cyclone. The pattern is consistent: the inquisition's enforcement priorities are determined by political calculation rather than by the pharmacological characteristics of the compounds involved. The drugs prosecuted were the drugs whose suppliers served no other strategic function. The drugs tolerated were the drugs whose suppliers were operationally useful. The same legal architecture that filled American prisons with cannabis users provided the cover under which intelligence-connected supply networks operated unmolested.
The most consequential institutional development of the late twentieth century, for the broader pharmacratic question, was the emergence of the modern pharmaceutical industry as the institutional priesthood that determines which psychoactive compounds are sacred and which are diabolical. The introduction of fluoxetine (Prozac) by Eli Lilly in 1987 inaugurated the SSRI era of antidepressant prescription. By 2000, approximately ten percent of American adults were receiving SSRI prescriptions. By 2020, the figure had risen to approximately thirteen percent. The SSRIs are, pharmacologically, psychoactive compounds that produce measurable changes in subjective experience, cognition, and behavior. They are sacramental within the institutional framework. They are administered by licensed practitioners under federal authorization. They are advertised to the public in mass media. They are consumed by tens of millions of Americans daily.
The opioid epidemic of the 1995-2017 period is the canonical contemporary case of the pharmaceutical sacrament's operational reality. Purdue Pharma's introduction of OxyContin in 1996, supported by the Sackler family's documented marketing campaign that systematically misrepresented the compound's addiction potential, produced an estimated 500,000 American overdose deaths across the next two decades. The compound is, pharmacologically, indistinguishable from heroin in its mechanism of action and addiction profile. Heroin is Schedule I. OxyContin is Schedule II. The legal distinction did not derive from any pharmacological property of the compounds. It derived from the institutional source of their distribution. A compound delivered through the pharmaceutical channel under physician prescription is sacred. A structurally identical compound delivered through any other channel is diabolical. Patrick Radden Keefe's Empire of Pain: The Secret History of the Sackler Dynasty (2021) is the principal investigative account; the federal Department of Justice's 2007 and 2020 settlements with Purdue Pharma and the criminal proceedings against the Sacklers document the institutional record beyond reasonable dispute.
The Adderall and methylphenidate (Ritalin) prescription apparatus is the pediatric instance of the same pattern. The compounds are amphetamines and amphetamine analogues, in the same pharmacological class as the methamphetamine that the federal scheduling system prohibits. The classification difference is institutional rather than pharmacological. The compounds are administered to approximately ten percent of American school-age boys, with the per-capita prescription rate in some American states substantially exceeding the per-capita rate at which methamphetamine is consumed in the broader population. The sacramental character of the prescription delivery channel — the physician, the pharmacy, the federal regulatory framework — converts a compound that would otherwise be Schedule II into a routine pediatric intervention. The structural identity of the compounds across the legal/illegal boundary is the clearest available illustration of the inquisition's contemporary operation. The pharmacology determines nothing. The institutional pathway determines everything.
The ketamine clinic boom of the post-2019 period, in which a Schedule III dissociative anesthetic has been increasingly prescribed off-label for treatment-resistant depression at compounding-pharmacy clinics across the United States, is the contemporary instance of the boundary's mobility. The compound is not new. Its antidepressant effects have been documented since the early 2000s. What changed was the institutional framework around it: the proliferation of ketamine prescription clinics, the FDA's 2019 approval of esketamine (Spravato) under a Risk Evaluation and Mitigation Strategy program, and the gradual normalization of dissociative-state-induced therapeutic experiences within the institutional pharmaceutical framework. The compound's pharmacology has not changed. The institutional acceptance has. The same molecule, used by the same population for the same purpose, was diabolical in 2010 and is sacramental in 2026. The criterion is not the compound. The criterion is whether the institutional pathway has incorporated it.
The aggregate human cost of the pharmacratic regime, across its post-Anslinger operational period, is the largest mass-incarceration system in modern history. The United States, with approximately four percent of the global population, holds approximately twenty percent of the world's prison population. Approximately twenty-five percent of American prisoners are incarcerated for drug-related offenses. The racial distribution of the incarceration is the racial distribution Anslinger and Ehrlichman designed: Black Americans are incarcerated for drug offenses at approximately five times the rate of white Americans, despite substantially identical use rates between the two populations. The Anti-Drug Abuse Act of 1986 — passed in the panic following the cocaine-overdose death of basketball player Len Bias — established the 100-to-1 sentencing disparity between crack cocaine (predominantly used by Black urban populations) and powder cocaine (predominantly used by white populations). The disparity was reduced to 18-to-1 by the Fair Sentencing Act of 2010 but has not been eliminated.
Michelle Alexander's The New Jim Crow: Mass Incarceration in the Age of Colorblindness (2010) is the canonical analysis of the racial mechanics. The drug-war prosecutorial apparatus has functioned, across the period since 1971, as a continuous mechanism for the criminalization, disenfranchisement, and economic marginalization of Black Americans on a scale that the post-Reconstruction Jim Crow regime did not approach. The political utility of this function — to the politicians who built the apparatus and to the bureaucracies that sustain it — is the structural answer to the question of why the Schafer Commission's recommendations, the Young decision, the Institute of Medicine's findings, and the accumulating contemporary research record have produced no substantial change in the federal scheduling regime over half a century. The regime is producing the outcomes for which it was designed. The fact that those outcomes are explicitly contradicted by the evidence on which the regime is officially defended does not constitute, within the institutional logic, a reason for reform. The regime is sacrificing whatever scientific credibility it once possessed in order to preserve the social-control function that is its actual operational purpose.
The federal prison population, which had stood at approximately 24,000 in 1980, rose to approximately 219,000 by 2013 — a ninefold increase across a period in which the American population increased by approximately forty percent. The state prison population followed a parallel trajectory. The aggregate prison population peaked at approximately 2.3 million in 2008. The principal proximate cause of the increase, as documented by the Bureau of Justice Statistics, was the application of mandatory minimum sentencing to drug offenses across the 1986-1994 period. The financial cost of the system, across the federal, state, and local levels, runs at approximately $80 billion per year. The opportunity cost — the human, social, and economic cost of removing approximately one in every hundred adult Americans from productive economic life and from their families — exceeds quantification.
The empirical case against the current scheduling regime is now overwhelming. The Johns Hopkins Center for Psychedelic and Consciousness Research, founded under Roland Griffiths in 2019 (the first formally constituted psychedelic research center at a major American academic institution since the 1960s closures), has produced a sequence of clinical trials documenting psilocybin's efficacy in treatment-resistant depression, end-of-life anxiety in cancer patients, tobacco-use disorder, and alcohol-use disorder. The Imperial College London Centre for Psychedelic Research under Robin Carhart-Harris has produced parallel work on the neuropharmacology and clinical efficacy of psilocybin and DMT. The Multidisciplinary Association for Psychedelic Studies (MAPS), under Rick Doblin's direction since its 1986 founding, completed Phase 3 trials of MDMA-assisted therapy for post-traumatic stress disorder in 2023, with reported efficacy substantially exceeding any existing pharmacological intervention. The Usona Institute's psilocybin-for-depression Phase 2 trials, the Compass Pathways Phase 2 program for treatment-resistant depression, and approximately a hundred ongoing clinical trials registered at ClinicalTrials.gov constitute, in aggregate, a research program whose scale and methodological rigor exceed any prior psychiatric research program of the modern era.
The substances classified by the Controlled Substances Act as having "no currently accepted medical use" are producing remission rates in treatment-resistant depression, end-of-life anxiety, addiction, and PTSD that exceed every existing pharmaceutical intervention by clinically significant margins. The criteria for Schedule I, on the substances' own merits, collapse. The FDA's 2018 Breakthrough Therapy designation for psilocybin in treatment-resistant depression, the 2017 designation for MDMA-assisted therapy for PTSD, and the 2024 advisory committee proceedings on the MAPS MDMA application have produced an institutional contradiction that the federal scheduling apparatus has yet to resolve. The agency is simultaneously certifying the therapeutic utility of compounds that another arm of the same federal government continues to classify as having no therapeutic utility. The contradiction will eventually resolve. The direction of resolution is not yet certain.
Oregon's Measure 109 in 2020 authorized supervised psilocybin therapy at the state level. Colorado's Proposition 122 in 2022 decriminalized personal use of psilocybin and several related compounds. The 2024 federal proposal to reschedule cannabis from Schedule I to Schedule III — under review at the DEA as of this writing — represents the first proposed substantive change to the federal scheduling architecture in fifty years. The state-level reforms have produced no documented public-health catastrophe. The arguments on which the original scheduling was based have been progressively withdrawn from public defense by the institutional advocates of the regime, replaced by procedural arguments about the difficulty of changing established federal rules. The regime's institutional defense has shifted, across the past decade, from the substantive defense of the scheduling decisions to the procedural defense of the institutional authority to make scheduling decisions. The defense is structural. It is no longer empirical, because the empirical defense is no longer available.
And yet the scheduling has not, at the federal level, substantially changed. Psilocybin remains Schedule I. DMT remains Schedule I. LSD remains Schedule I. Cannabis, as of this writing, remains Schedule I at the federal level — though the DEA's 2024 proposal to move it to Schedule III indicates the machine is capable of movement when the political cost of inertia becomes large enough. The delay between scientific consensus and legal reclassification is not, McKenna's argument holds, a bureaucratic lag. It is the system functioning as designed. The inquisition does not reclassify its heretics on the basis of evidence. It reclassifies them when the cost of continuing to burn them exceeds the cost of admitting it was wrong.
The pharmacratic inquisition, in McKenna's framing and in the material that Szasz, Harner, Hari, Kinzer, Lee and Shlain, and Patrick Radden Keefe have subsequently documented, is not a series of unfortunate policy choices. It is a single, coherent, multi-century operation — carried out by different institutions under different ideological pretexts, but serving a consistent function. Human beings are the animals that can modify their own Consciousness. The cultures that preserve, ritualize, and transmit the techniques for doing so produce populations that ruling powers find difficult to manage. Populations that experience, even once, the dissolution of the narrative self — the collapse of the boundaries that separate them from other beings, from the natural world, from what some of them will subsequently call God — are populations that are harder to mobilize for war, harder to organize into consumption, harder to police into political quiescence. The keys to those states are the plants. The plants, accordingly, must be taken away.
What connects Eleusis to the Marihuana Tax Act, the Inquisition's peyote edicts to Schedule I, the burning of village herbalists to the War on Drugs, is not that the same men ran them. It is that the same function was served. A ruling order, whatever its theology, reserves for itself the right to determine what minds are permitted to do. The sacraments of the new order are issued by pharmaceutical corporations and prescribed by licensed physicians. The sacraments of every older order — the mushroom, the vine, the cactus, the seed — are designated diabolical, medicalized as addiction, and enforced against by armed men. The institutional vocabulary changes across centuries. The operational structure does not. A monopoly on legitimate access to altered states of consciousness is the form of power most consistently sought by the ruling institutions of every civilization that has retained centralized authority for any extended period. The pharmacratic regime is the contemporary form of that monopoly. It is not new. It is not American. It is not a 1937 invention or a 1971 invention. It is the most durable institutional pattern in the history of organized human society.
MKUltra is the proof that the ruling order does not disbelieve the plants' power. It knows what they can do. That is precisely why the public is not permitted to have them. The Eleusinian initiates and the Mazatec curanderas and the suburban mother who micro-doses psilocybin for treatment-resistant depression are doing the same thing the Big Pharma and the Vaccine Conspiracy industry's clinical trials are now formally documenting and the federal scheduling regime has criminalized for half a century. The compounds work. They have always worked. The question of whether they will be made institutionally available to the populations that need them — and on what terms, with what gatekeepers, under what corporate ownership of the resulting therapeutic infrastructure — is the open question of the next two decades. The inquisition, in McKenna's hands, is not a metaphor. It is the operating principle of every civilization that has survived for very long by convincing the governed that the doors are walls. What happens when the doors begin to open again is a question the historical record does not yet answer, because every previous attempt to open the doors has been suppressed before the answer became visible.